Brief: Stayble Therapeutics Q2 EBIT Loss Narrows To SEK 1.9 Mln
20/08/2025 12:43
Aug 20 (Reuters) - Stayble Therapeutics AB STABL.ST: Q2 EBIT LOSS SEK 1.9 MILLION VERSUS LOSS SEK 3.4 MILLION YEAR AGO Source text: ID:nWkr3RWNfJ Further company coverage: STABL.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Stayble Therapeutics AB
See all newsBrief: Stayble Therapeutics Delisted From Nasdaq First North Growth Market
Brief: Stayble Therapeutics To Apply For Bankruptcy
Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
Brief: Stayble Therapeutics Q4 Oper Loss To SEK 1.5 Mln